Dual-Release Brain Health Composition for Sustained Focus
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current focus support supplements, such as ADHD medications and over-the-counter brain stimulants, often come with severe side effects like insomnia, anxiety, and irritability, while mushroom supplements have inconsistent efficacy, necessitating a need for compositions that enhance focus, mood, and alertness without these drawbacks.
Innovation Solution
Brain health compositions comprising Coffea extract, coffeeberry extract, and a combination of caffeine, theacrine, methylliberine, and theanine, which provide sustained energy and improved cognitive function by gradual caffeine release, mitigating side effects and enhancing cognitive benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If high doses of caffeine are used to improve focus and alertness, then cognitive performance is enhanced, but side effects such as jitters, anxiety, insomnia, and increased heart rate occur
Solution Approach 1:
The patent segments the total caffeine dose into two distinct release phases: an instant-release component (60-140 mg) for immediate cognitive enhancement and a sustained-release component (40-80 mg) for prolonged effect. This segmentation allows the user to receive the full 100-220 mg caffeine dose while experiencing reduced peak-related side effects, as the gradual release prevents overwhelming the cardiovascular and nervous systems.
Solution Approach 2:
The sustained-release caffeine component is designed to release caffeine gradually over 6-8 hours, anticipating and preventing the crash that typically follows instant caffeine consumption. This preliminary action of controlled release ensures steady plasma caffeine levels, maintaining focus and alertness without the subsequent drop that causes jitters and anxiety.
2Productivity
If classic ADHD medications like ADDERALL are used to improve focus, then attention and concentration are enhanced, but severe side effects including insomnia, nausea, anxiety, and irritability occur
Solution Approach 1:
The patent changes the chemical delivery parameters by using caffeine (a methylxanthine) instead of amphetamines or stimulants. This parameter change in the active ingredient, combined with the dual-release formulation, achieves focus enhancement through adenosine receptor antagonism rather than dopamine release, thereby avoiding the severe side effects associated with traditional ADHD medications while maintaining cognitive benefits.
3Productivity
If over the counter brain stimulants with high caffeine content are used to improve focus, then alertness is enhanced, but dependence is formed and problematic side effects occur
Solution Approach 1:
The patent introduces dynamic control over caffeine release through the combination of instant-release and sustained-release mechanisms. This dynamic delivery system adapts the caffeine release rate to match the body's metabolic processing, maintaining alertness without creating the harsh withdrawal symptoms and dependence associated with static, high-dose caffeine products. The extended 6-8 hour release window reduces the need for repeated dosing, thereby reducing dependence risk.
Data Source
AI summary
Brain health compositions are described herein. For example, this document provides brain health compositions containing a Coffea extract and/or dried Coffea (e.g., a coffeeberry extract), caffeine (e.g., instant release caffeine and/or sustained release caffeine), theacrine, and methylliberine. Such compositions may be used to, e.g., help improve executive functioning, reduce testing errors, and/or provide even greater improvement in general alertness, attention, brain power, and reaction time over caffeine alone.